OBiS

OBiS (OncoBusiness Information Systems) is an oncology-focused technology and clinical research services company providing data-driven solutions to accelerate drug development. The firm specializes in optimizing clinical trial efficiency through proprietary informatics platforms, including OncoTrialMatch and OncoSearch, which facilitate patient recruitment and site selection. OBiS is notably the technology partner and co-founder of OncoBay Clinical, a specialist oncology contract research organization (CRO) that was a joint venture with the Moffitt Cancer Center before its acquisition by Labcorp in 2023. Led by clinical oncologists and industry veterans, OBiS provides pharmaceutical and biotech clients with market intelligence and strategic insights to overcome barriers in cancer clinical trials. The company's tools are designed to streamline the accrual process and enhance the probability of success for complex oncology programs.